Related Experiment Video
Updated: Jun 25, 2025

Oligopeptide Competition Assay for Phosphorylation Site Determination
Published on: May 18, 2017
Energy stress-activated AMPK phosphorylates Snail1 and suppresses its stability and oncogenic function
Mei Li1, Litao Zhang2, Tangming Guan1
1State Key Laboratory of Bioactive Molecules and Druggability Assessment/International Cooperative Laboratory of Traditional Chinese Medicine Modernization and Innovative Drug Development of Ministry of Education (MOE) of China/College of Pharmacy, Jinan University, Guangzhou, 510632, China.
Abstract:
Triple-negative breast cancer (TNBC) is a highly lethal malignancy with limited therapy options. Aberrant metabolism, a key hallmark of human cancers, plays a crucial role in tumor progression, therapeutic responses and TNBC-related death. However, the underlying mechanisms are not fully understood. In this study, we delineate a previously unrecognized role of aberrant glucose metabolism in regulating the turnover of Snail1, which is a key transcriptional factor of epithelial-mesenchymal transition (EMT) and critically contributes to the acquisition of stemness, metastasis and chemo-resistance. Mechanistically, we demonstrate that AMP-activated protein kinase (AMPK), when activated in response to glucose deprivation, directly phosphorylates Snail1 at Ser11. Such a phosphorylation modification of Snail1 facilitates its recruitment of the E3 ligase FBXO11 and promotes its degradation, thereby suppressing stemness, metastasis and increasing cellular sensitivity to chemotherapies in vitro and in vivo. Clinically, histological analyses reveal a negative correlation between p-AMPKα and Snail1 in TNBC specimens. Taken together, our findings establish a novel mechanism and functional significance of AMPK in linking glucose status to Snail1-dependent malignancies and underscore the potential of AMPK agonists as a promising therapeutic strategy in the management of TNBC.
Insights
AMP-activated protein kinase (AMPK) activation suppresses triple-negative breast cancer (TNBC) progression by targeting Snail1 degradation. This discovery offers a potential new therapeutic strategy for TNBC management.
Area of Science:
- Molecular oncology
- Cancer metabolism
- Signal transduction
Background:
- Triple-negative breast cancer (TNBC) is aggressive with limited treatment options.
- Aberrant cancer metabolism influences tumor progression and therapeutic resistance.
- The role of glucose metabolism in TNBC progression requires further elucidation.
Purpose of the Study:
- To investigate the role of aberrant glucose metabolism in regulating Snail1 turnover in TNBC.
- To identify the mechanisms linking glucose metabolism to Snail1-mediated TNBC progression.
- To explore the therapeutic potential of targeting this pathway in TNBC.
Main Methods:
- Investigated the effect of glucose deprivation on Snail1 regulation.
- Utilized biochemical assays to determine AMP-activated protein kinase (AMPK) phosphorylation of Snail1.
- Assessed the impact of Snail1 phosphorylation on its interaction with FBXO11 and subsequent degradation.
- Performed in vitro and in vivo experiments to evaluate the functional consequences of this pathway.
- Conducted histological analyses of TNBC specimens to correlate p-AMPKα and Snail1 levels.
Main Results:
- Glucose deprivation activates AMPK, leading to direct phosphorylation of Snail1 at Ser11.
- Phosphorylated Snail1 is recruited by the E3 ligase FBXO11, promoting its degradation.
- Suppression of Snail1 by AMPK activation reduces stemness, metastasis, and chemo-resistance in TNBC.
- Clinical data show an inverse correlation between p-AMPKα and Snail1 in TNBC tissues.
Conclusions:
- AMPK activation links glucose metabolism to Snail1 degradation, suppressing TNBC stemness, metastasis, and chemo-resistance.
- This study reveals a novel mechanism regulating Snail1 turnover.
- AMPK agonists represent a promising therapeutic strategy for TNBC management.
More Related Videos
07:39Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
Published on: June 6, 2025
06:51Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
Published on: July 21, 2018
Related Concept Videos
PI3K/mTOR/AKT Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
The JAK-STAT Signaling Pathway
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Amplifying Signals via Enzymatic Cascade
MAPK Signaling Cascades